Ocumetics Technology Corp. (TSXV: OTC)

Ocumetics Technology Income Statement

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jul 31, 2021	Jul 31, 2020
Selling, General & Admin	1.34	2.09	1	1.1	0.56	0.1
Research & Development	0.98	0.91	0.56	0.24	-	-
Operating Expenses	2.74	3.61	2.14	2.01	0.65	0.17
Operating Income	-2.74	-3.61	-2.14	-2.01	-0.65	-0.17
Interest Expense	-0.11	-0.03	-0.03	-0.03	-	-
Currency Exchange Gain (Loss)	-0.03	-0.01	-0.01	-0	-	-
Other Non Operating Income (Expenses)	0.01	-	-	-0.14	-	-
EBT Excluding Unusual Items	-2.87	-3.64	-2.18	-2.17	-0.65	-0.17
Other Unusual Items	-	-	-0.04	-1.37	-	-
Pretax Income	-2.87	-3.64	-2.22	-3.54	-0.65	-0.17
Net Income	-2.87	-3.64	-2.22	-3.54	-0.65	-0.17
Net Income to Common	-2.87	-3.64	-2.22	-3.54	-0.65	-0.17
Shares Outstanding (Basic)	119	115	110	104	68	22
Shares Outstanding (Diluted)	119	115	110	104	68	22
Shares Change (YoY)	6.23%	5.15%	5.93%	52.00%	206.74%	0.06%
EPS (Basic)	-0.02	-0.03	-0.02	-0.03	-0.01	-0.01
EPS (Diluted)	-0.02	-0.03	-0.02	-0.03	-0.01	-0.01
Free Cash Flow	-2.45	-2.12	-1.62	-2.45	-0.09	-0
Free Cash Flow Per Share	-0.02	-0.02	-0.01	-0.02	-0.00	-0.00
EBITDA	-2.59	-3.49	-2.04	-1.91	-0.56	-0.1
D&A For EBITDA	0.15	0.12	0.1	0.1	0.08	0.07
EBIT	-2.74	-3.61	-2.14	-2.01	-0.65	-0.17

Source: S&P Capital IQ. Standard template. Financial Sources.